EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+4.07%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$248M
AUM Growth
+$248M
(-8.2%)
Cap. Flow
-$3.24M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
65.09%
Holding
42
New
10
Increased
7
Reduced
9
Closed
6
Top Buys
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$13.6M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
$10.9M |
| 3 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$10.5M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$7.13M |
| 5 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$7.07M |
Top Sells
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$44.5M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$8.87M |
| 3 |
FibroGen
FGEN
|
$7.51M |
| 4 |
Tempest Therapeutics
TPST
|
$4.15M |
| 5 |
GNVC
GenVec, Inc.
GNVC
|
$3.53M |
Sector Composition
| 1 | Healthcare | 79.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ironwood Pharmaceuticals
IRWD
$214M
| $22.6M | 7.88% | 2,061,417 +1,239,886 | +151% | +$13.6M |
|
|
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $20.3M | 7.11% | 500,757 -218,243 | -30% | -$8.87M |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $19.4M | 6.77% | 1,598,900 +900,000 | +129% | +$10.9M |
|
|
4
FibroGen
FGEN
$47.8M
| $18.4M | 6.43% | 863,745 -352,728 | -29% | -$7.51M |
|
5
Travere Therapeutics
TVTX
$1.56B
| $16.7M | 5.85% | 1,225,084 +700 | +0.1% | +$9.56K |
|
6
Cytokinetics
CYTK
$4.23B
| $14.5M | 5.06% | 2,052,800 +634,100 | +45% | +$4.47M |
|
7
Assembly Biosciences
ASMB
$190M
| $10.5M | 3.68% | 2,098,302 | – | – |
|
|
CPXX
8
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $10.5M | 3.66% | +950,000 | New | +$10.5M |
|
9
Galapagos
GLPG
$2.07B
| $10.3M | 3.6% | 246,691 +79,330 | +47% | +$3.32M |
|
10
Kura Oncology
KURA
$686M
| $9.98M | 3.49% | 2,465,286 +15,286 | +0.6% | +$61.9K |
|
11
Collegium Pharmaceutical
COLL
$1.22B
| $8.59M | 3% | 473,123 +8,005 | +2% | +$145K |
|
|
XLRN
12
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.13M | 2.49% | +270,289 | New | +$7.13M |
|
|
AIMT
13
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $7.07M | 2.47% | +521,366 | New | +$7.07M |
|
14
Enanta Pharmaceuticals
ENTA
$180M
| $7.06M | 2.47% | +240,383 | New | +$7.06M |
|
|
KITE
15
DELISTED
Kite Pharma, Inc.
KITE
| $6.89M | 2.41% | 150,000 -16,000 | -10% | -$735K |
|
16
Syndax Pharmaceuticals
SNDX
$1.41B
| $6.8M | 2.38% | +510,829 | New | +$6.8M |
|
|
NBRV
17
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $6.34M | 2.22% | 707,817 -130,863 | -16% | -$1.17M |
|
18
Salarius Pharmaceuticals
SLRX
$2.94M
| $6.32M | 2.21% | 575,925 -219,163 | -28% | -$2.4M |
|
|
KIN
19
DELISTED
Kindred Biosciences, Inc.
KIN
| $4.94M | 1.73% | 1,432,765 | – | – |
|
|
LOXO
20
DELISTED
Loxo Oncology, Inc
LOXO
| $4.11M | 1.44% | +150,308 | New | +$4.11M |
|
|
EIGR
21
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.18M | 1.11% | 189,545 -2,653,625 | -93% | -$44.5M |
|
22
Editas Medicine
EDIT
$231M
| $3.04M | 1.06% | +87,921 | New | +$3.04M |
|
|
FWP
23
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $1.65M | 0.58% | 97,024 -2,993 | -3% | -$50.9K |
|
|
AKTX
24
Akari Therapeutics
AKTX
$24.8M
| $1.29M | 0.45% | 92,303 -8,447 | -8% | -$118K |
|
|
ONC
25
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $462K | 0.16% | +15,766 | New | +$462K |
|